Neuroendocrine Tumor | Dr. Tony Talebi discusses the Treatment of Neuroendocrine Tumor?
Dr. Tony Talebi discusses the Treatment of Neuroendocrine Tumors with Dr. Strosberg. For further discussion visit http://www.HemOnc101.com
Dr. Tony Talebi is a Board Certified Hematologist/Oncologist and his private practice, Miami Hematology & Oncology Associates, is located at 151 NW 11th Ave, Suite 303W, Florida 33030. Telephone 786-504-3084, Fax 786-304-3086
What is the Treatment of Neuroendocrine Tumors?
Neuroendocrine tumors are a heterogeneous group of neoplasms that vary in their appearance, biologic behavior, symptoms, and response to treatment. Several types of neuroendocrine tumors (eg, carcinoid tumors, pancreatic neuroendocrine tumors, medullary thyroid cancers, pheochromocytomas) are characterized by slow growth and frequent secretion of hormones or vasoactive substances. In most cases, these tumors also have typical histologic appearance and are accurately diagnosed with standard pathologic methods (light microscopy and immunohistochemical staining). Other neuroendocrine tumors, typified by small cell carcinoma of the lung, are highly aggressive neoplasms, and are usually advanced when diagnosed.
Well differentiated neuroendocrine tumors originating in the gastrointestinal tract (carcinoid, pancreatic neuroendocrine tumors) are the most common neuroendocrine tumors. However, these are not the most common neuroendocrine tumors presenting with unknown primary site, since most are diagnosed at an early stage and cured by surgical resection.
Poorly differentiated neuroendocrine tumors are characterized by multiple sites of metastases and rarely produce symptoms related to secretion of bioactive substances. Accurate distinction of well differentiated, indolent tumors from poorly differentiated, aggressive tumors is important, since treatment approaches are different
Here, Dr. Tony Talebi discusses the treatment of neuroendocrine tumors with Dr. Jonathan Strosberg, an assitant professor of medicine at the Lee Moffitt Comprehensive Cancer Center and a specialist in neuroendocrine tumors.
Dr. Strosberg credentials:
Faculty Rank:
Assistant Member
Titles:
Department/Program Affiliations:
Experimental Therapeutics
Gastrointestinal Tumor
Primary Address:
H. Lee Moffitt Cancer Center &
Research Institute
Education & Training:
BA, Harvard University, 1995
MD, Cornell University Medical College, 1999
Resident, Georgetown University Hospital, 2001 - General Internal Medicine
Fellow, H. Lee Moffitt Cancer Center & Research Institute, 2006 - Medical Oncology & Hematology
General Board Certification / SubSpecialty:
Internal Medicine / Hematology
Internal Medicine / Medical Oncology
-
Category
No comments found